Predisposition to Cancer
You may also be interested in our brochure MLPA for Predisposition to Cancer (link opens in a new window).

Product NameApplicationRegion
ME011-MMRimproved Mismatch repair genes (MMR) MLH1, MSH2, MSH6, PMS2, EPCAM, BRAF V600E
ME024-9p21 Tumours, Cutaneous melanoma 9p21, CDKN2A, CDKN2B
P002-BRCA1CE Hereditary breast cancer (BRCA1) BRCA1 17q21.31
P003-MLH1/MSH2CE Lynch Syndrome MLH1 3p22.2, MSH2 2p21
P008-PMS2CE Lynch Syndrome PMS2 7p22
P016-VHLCE Von Hippel-Lindau Syndrome VHL, 3p25
P017-MEN1 Multiple endocrine neoplasia MEN1 11q13
P031-FANCA mix 1 Fanconi Anemia (FA) FANCA 16q24.3
P032-FANCA mix 2 Fanconi Anemia (FA) FANCA 16q24.3
P041-ATM-1CE Ataxia-Telangiectasia (AT) ATM 11q23
P042-ATM-2CE Ataxia-Telangiectasia (AT) ATM 11q23
P043-APCCE Hereditary Polyposis Colon Cancer APC, 5q21-q22
P044-NF2 Neurofibromatosis type 2 (NF2) NF2 22q12
P045-BRCA2/CHEK2CE Breast cancer, hereditary BRCA2, CHEK2
P046-TSC2 Tuberous Sclerosis TSC2 16p13.3
P047-RB1 Retinoblastoma (RB) RB1 13q14
P056-TP53CE Li-Fraumeni syndrome (LFS) and tumour analysis TP53 17p13.1
P057-FANCD2-PALB2 Fanconi anemia (FA) FANCD2. 3p25.3, PALB2 16p12
P067-PTCH1 Gorlin syndrome PTCH1 9q22.3
P072-MSH6 Lynch Syndrome MSH6, MUTYH, EPCAM
P077-BRCA2 ConfirmationCE Breast cancer, hereditary BRCA2
P081-NF1 mix 1CE Neurofibromatosis NF1 17q11.2
P082-NF1 mix 2CE Neurofibromatosis NF1 17q11.2
P083-CDH1CE Hereditary diffuse gastric cancer CDH1 at 16q22.1
P087-BRCA1 ConfirmationCE Breast cancer, hereditary BRCA1
P090-BRCA2CE Breast cancer, hereditary BRCA2 13q13.1
P101-STK11CE Peutz-Jeghers syndrome (PJS) STK11 19p13.3
P113-FANCB Fanconi anemia complementation group B FANCB Xp22
P118-WT1 Wilms tumours, WAGR, Denys-Drash, Frasier syndrome. WT1 11p13
P122-NF1-area Neurofibromatosis NF1 17q11.2
P124-TSC1CE Tuberous Sclerosis TSC1 9q34
P158-JPS Juvenile polyposis syndrome (JPS) BMPR1A 10q23, SMAD4 18q21, PTEN 10q23
P190-CHEK2CEimproved Breast cancer susceptibility CHEK2 22q12, ATM, TP53
P215-EXT Multiple Osteochondromas EXT1 8q24, EXT2 11p11
P225-PTEN PTEN hamartoma tumor syndrome, Cowden syndrome 1, Bannayan-Riley-Ruvalcaba syndrome, PTEN-related Proteus syndrome, Proteus-like syndrome and tumour analysis PTEN 10q23
P226-SDHCE Paragangliomas (PGL) SDHD 11q23.1, SDHB 1p36.1, SDHC 1q23.3, SDHAF1 19q13, SDHAF2 11q12
P239-BRCA1 region Breast cancer BRCA1 region
P240-BRIP1/CHEK1 Hereditary predisposition to Cancer BRIP1 17q22, CHEK1 11q22
P244-AIP-MEN1-CDKN1B Multiple endocrine neoplasia (MEN) AIP 11q13, MEN1 11q13, CDKN1B 12p13
P248-MLH1-MSH2 Confirmation Lynch Syndrome MLH1 3p21.3, MSH2 2p21
P258-SMARCB1 Rhabdoid tumors SMARCB1 22q11.2
P260-PALB2-RAD50-RAD51C-RAD51DCE Hereditary predisposition to Cancer 5q31, 16p12, 17q12, 17q22
P308-MET Papillary renal carcinoma, various cancers MET 7q31, PTEN 10q23.31, LRRK2 12q12
P337-TSC2 Tuberous sclerosis TSC2 gene, 16p13.3
P378-MUTYHCE Colon cancer, stomach cancer (hereditary) 1p34 and 15q13
P417-BAP1 Melanocytic tumours, mesothelioma BAP1, 3p21.1
P419-CDKN2A/2B-CDK4 Familial melanoma CDKN2A, CDKN2B, CDK4, MITF E318K
P429-SDHA-MAX Paraganglioma and pheochromocytoma 5p15.3 and 14q23.3
Newsletter  |  Home  |  Site map  |  Terms and Conditions  |  Search  |  Copyright © 2018 MRC-Holland